Abbott Labs Rolling Out Coronavirus Antibody Tests [Forbes]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Forbes
Abbott Laboratories is launching a laboratory based blood test designed to detect antibodies to identify whether someone has had the Coronavirus strain COVID-19.
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its "buy" rating re-affirmed by analysts at Raymond James. They now have a $129.00 price target on the stock, up previously from $122.00.MarketBeat
- Abbott's Q3 Earnings Release Coming Up, EPD Business in Focus [Yahoo! Finance]Yahoo! Finance
- Diabetes Products To Drive Abbott's Q3 [Forbes]Forbes
- Gastrointestinal Diseases Therapeutics Market to Grow by USD 18.5 Billion from 2024-2028 Driven by Rising Disease Incidence, with AI Shaping Market Trends - Technavio [Yahoo! Finance]Yahoo! Finance
- Embolization Coil Market to Grow by USD 538.3 Million from 2024-2028 Driven by Rising Incidence of Aneurysms, Report on AI-Driven Market Transformation - Technavio [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 7/18/24 - Beat
ABT
Sec Filings
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- ABT's page on the SEC website